NANOVIRICIDES, INC.

For the period ended Jun 30, 2026. Filed Sep 28, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Sep 28, 2026

NNVC$1.42+6.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets at June 30, 2026 and 2025

Balance Sheet


· · June 30, 2026 · · June 30, 2025

ASSETS · · · ·
CURRENT ASSETS: · · · ·
Cash and cash equivalents	$2,794,110	$1,558,564
Prepaid expenses	368,513	112,146
Total current assets	3,162,623	1,670,710

Property and equipment, net	6,401,192	6,833,891

Intangible assets, net	308,769	317,039

OTHER ASSETS
Service agreements	1,030	2,445

Total assets	$9,873,614	$8,824,085

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$323,816	$459,094
Accounts payable – related party	828,577	821,456
Accrued expenses	38,331	25,969
Total current liabilities	1,190,724	1,306,519

COMMITMENTS AND CONTINGENCIES (NOTE 11)

STOCKHOLDERS’ EQUITY:
Series A convertible preferred stock, $0.00001 par value, 10,000,000 shares designated, 918,809 and 905,717 shares issued and outstanding, at June 30, 2026 and 2025, respectively. (Note 9)	9	9
Common stock, $0.00001 par value; 150,000,000 shares authorized, 23,008,308 and 16,606,832 shares issued and outstanding at June 30, 2026 and 2025, respectively. (Note 8)	230	166
Additional paid-in capital	165,743,021	156,359,252
Accumulated deficit	(157,060,370)	(148,841,861)
Total stockholders’ equity	8,682,890	7,517,566
Total liabilities and stockholders’ equity	$9,873,614	$8,824,085

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.